(Q83363712)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

The role of minor subpopulations within the leukemic blast compartment of AML patients at initial diagnosis in the development of relapse (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

G J Schuurhuis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Y G Assaraf

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Z J Kwidama

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

A Kelder

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

F Wouters

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

A N Snel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

G J L Kaspers

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

J Cloos

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

13 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1313-1320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289983%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2011.383

21 January 2020

exact match

0 references

cites work

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Pediatric acute myeloid leukemia: towards high-quality cure of all patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Pediatric acute myeloid leukemia: international progress and future directions

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Management of relapsed acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

The roles of FLT3 in hematopoiesis and leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Targeting the leukemic stem cell: the Holy Grail of leukemia therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Targeted therapies: the rare cancer paradigm

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibit

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Evolution of FLT3-ITD and D835 activating point mutations in relapsing acute myeloid leukemia and response to salvage therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Lineage ambiguity, infidelity, and promiscuity in immunophenotypically complex acute leukemias: genetic and morphologic correlates

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Unique molecular and cellular features of acute myelogenous leukemia stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus -negative leukemia cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Assessment of minimal residual disease in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021

Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)].

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.383

7 January 2021